222 related articles for article (PubMed ID: 27180036)
1. Conversion from MCI to AD in patients with the APOE ε4 genotype: Prediction by plasma HCY and serum BDNF.
Zheng L; Kong X; Cui Y; Wei Y; Zhang J; Wei W
Neurosci Lett; 2016 Jul; 626():19-24. PubMed ID: 27180036
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of hippocampal volume and serum brain-derived neurotrophic factor as potential diagnostic markers of conversion from amnestic mild cognitive impairment to Alzheimer disease: A STROBE-compliant article.
Fang Y; Du N; Xing L; Duo Y; Zheng L
Medicine (Baltimore); 2019 Jul; 98(30):e16604. PubMed ID: 31348306
[TBL] [Abstract][Full Text] [Related]
3. Combining serum and urine biomarkers in the early diagnosis of mild cognitive impairment that evolves into Alzheimer's disease in patients with the apolipoprotein E ϵ4 genotype.
Wang C; Cui Y; Yang J; Zhang J; Yuan D; Wei Y; Li Y; Duo Y; Li S; Zhu W; Zheng L
Biomarkers; 2015 Feb; 20(1):84-8. PubMed ID: 25532446
[TBL] [Abstract][Full Text] [Related]
4. Distribution and clinical impact of apolipoprotein E4 in subjective memory impairment and early mild cognitive impairment.
Cho H; Kim YE; Chae W; Kim KW; Kim JW; Kim HJ; Na DL; Ki CS; Seo SW
Sci Rep; 2020 Aug; 10(1):13365. PubMed ID: 32770103
[TBL] [Abstract][Full Text] [Related]
5. Neuroimaging basis in the conversion of aMCI patients with APOE-ε4 to AD: study protocol of a prospective diagnostic trial.
Chen GQ; Sheng C; Li YX; Yu Y; Wang XN; Sun Y; Li HY; Li XY; Xie YY; Han Y
BMC Neurol; 2016 May; 16():64. PubMed ID: 27176479
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of APOE-ε4 allele for progression from MCI to AD-type dementia: a meta-analysis.
Elias-Sonnenschein LS; Viechtbauer W; Ramakers IH; Verhey FR; Visser PJ
J Neurol Neurosurg Psychiatry; 2011 Oct; 82(10):1149-56. PubMed ID: 21493755
[TBL] [Abstract][Full Text] [Related]
7. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
Löwe LC; Gaser C; Franke K;
PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
[TBL] [Abstract][Full Text] [Related]
8. Mild behavioral impairment in early Alzheimer's disease and its association with APOE and BDNF risk genetic polymorphisms.
Matuskova V; Veverova K; Jester DJ; Matoska V; Ismail Z; Sheardova K; Horakova H; Cerman J; Laczó J; Andel R; Hort J; Vyhnalek M
Alzheimers Res Ther; 2024 Jan; 16(1):21. PubMed ID: 38279143
[TBL] [Abstract][Full Text] [Related]
9. DNA Methylation and Tag SNPs of the BDNF Gene in Conversion of Amnestic Mild Cognitive Impairment into Alzheimer's Disease: A Cross-Sectional Cohort Study.
Xie B; Liu Z; Liu W; Jiang L; Zhang R; Cui D; Zhang Q; Xu S
J Alzheimers Dis; 2017; 58(1):263-274. PubMed ID: 28387675
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E genotypes and plasma levels in mild cognitive impairment conversion to Alzheimer's disease: A follow-up study.
Scarabino D; Broggio E; Gambina G; Maida C; Gaudio MR; Corbo RM
Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1131-1138. PubMed ID: 27604972
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
12. Associations Between ApoEε4 Carrier Status and Serum BDNF Levels--New Insights into the Molecular Mechanism of ApoEε4 Actions in Alzheimer's Disease.
Liu YH; Jiao SS; Wang YR; Bu XL; Yao XQ; Xiang Y; Wang QH; Wang L; Deng J; Li J; Zhou XF; Zhou HD; Wang YJ
Mol Neurobiol; 2015; 51(3):1271-7. PubMed ID: 24986007
[TBL] [Abstract][Full Text] [Related]
13. Progression from MCI to AD: predictive value of CSF Aβ42 is modified by APOE genotype.
Kester MI; Verwey NA; van Elk EJ; Blankenstein MA; Scheltens P; van der Flier WM
Neurobiol Aging; 2011 Aug; 32(8):1372-8. PubMed ID: 19748159
[TBL] [Abstract][Full Text] [Related]
14. [Effect of apolipoprotein E genotype on magnetic resonance spectrum in amnestic mild cognitive impairment and Alzheimer's disease patients].
Zhu XQ; Zhou X; Zhao W; Zhang YM; Liu FJ; Cao J; Sun ZW
Zhonghua Yi Xue Za Zhi; 2019 Apr; 99(15):1156-1161. PubMed ID: 31006219
[No Abstract] [Full Text] [Related]
15. Association between DCHS2 gene and mild cognitive impairment and Alzheimer's disease in an elderly Brazilian sample.
Vieira RN; Ávila R; de Paula JJ; Cintra MT; de Souza RP; Nicolato R; Malloy-Diniz L; de Miranda DM; de Moraes EN; de Marco LA; Romano-Silva MA; Bicalho MA
Int J Geriatr Psychiatry; 2016 Dec; 31(12):1337-1344. PubMed ID: 26876984
[TBL] [Abstract][Full Text] [Related]
16. Predictability of polygenic risk score for progression to dementia and its interaction with APOE ε4 in mild cognitive impairment.
Pyun JM; Park YH; Lee KJ; Kim S; Saykin AJ; Nho K;
Transl Neurodegener; 2021 Aug; 10(1):32. PubMed ID: 34465370
[TBL] [Abstract][Full Text] [Related]
17. Accelerated progression from mild cognitive impairment to dementia among APOE ε4ε4 carriers.
Xu WL; Caracciolo B; Wang HX; Santoni G; Winblad B; Fratiglioni L
J Alzheimers Dis; 2013; 33(2):507-15. PubMed ID: 23247007
[TBL] [Abstract][Full Text] [Related]
18. Motor timing intraindividual variability in amnestic mild cognitive impairment and cognitively intact elders at genetic risk for Alzheimer's disease.
Kay CD; Seidenberg M; Durgerian S; Nielson KA; Smith JC; Woodard JL; Rao SM
J Clin Exp Neuropsychol; 2017 Nov; 39(9):866-875. PubMed ID: 28052734
[TBL] [Abstract][Full Text] [Related]
19. The APOE ε4 allele is associated with increased frontally mediated neurobehavioral symptoms in amnestic MCI.
Mikos AE; Piryatinsky I; Tremont G; Malloy PF
Alzheimer Dis Assoc Disord; 2013; 27(2):109-15. PubMed ID: 22874659
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of APOE epsilon 2 on intrinsic functional connectivity of the entorhinal cortex is associated with better episodic memory in elderly individuals with risk factors for Alzheimer's disease.
Chen J; Shu H; Wang Z; Liu D; Shi Y; Xu L; Zhang Z
Oncotarget; 2016 Sep; 7(37):58789-58801. PubMed ID: 27542235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
